Found: 66
Select item for more details and to access through your institution.
Intermediate- and high-risk melanoma.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Improving Survival in Patients with High-Risk and Metastatic Melanoma: Immunotherapy Leads the Way.
- Published in:
- American Journal of Clinical Dermatology, 2003, v. 4, n. 5, p. 333, doi. 10.2165/00128071-200304050-00004
- By:
- Publication type:
- Article
Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 2, p. 356, doi. 10.1245/s10434-017-6267-7
- By:
- Publication type:
- Article
Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2016, v. 23, n. 4, p. 1309, doi. 10.1245/s10434-015-4968-3
- By:
- Publication type:
- Article
Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 7, p. 2135, doi. 10.1245/s10434-014-4169-5
- By:
- Publication type:
- Article
Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2012, v. 19, n. 11, p. 3313, doi. 10.1245/s10434-012-2475-3
- By:
- Publication type:
- Article
Long-Term Results of a Phase III Randomized Trial of Postoperative Radiotherapy With or Without Carboplatin in Patients With High-Risk Head and Neck Cancer.
- Published in:
- Laryngoscope, 2008, v. 118, n. 3, p. 444, doi. 10.1097/MLG.0b013e31815b48f4
- By:
- Publication type:
- Article
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy).
- Published in:
- Journal of Translational Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12967-022-03592-4
- By:
- Publication type:
- Article
Erratum to: Progression of cutaneous melanoma: implications for treatment.
- Published in:
- 2012
- By:
- Publication type:
- Correction Notice
Progression of cutaneous melanoma: implications for treatment.
- Published in:
- Clinical & Experimental Metastasis, 2012, v. 29, n. 7, p. 775, doi. 10.1007/s10585-012-9521-1
- By:
- Publication type:
- Article
Patient-Focused Treatment Decisions in the Management of Metastatic Melanoma: A Close Look at the Evolving Role of Immunotherapy.
- Published in:
- Journal of Managed Care Medicine, 2022, v. 25, n. 4, p. 36
- By:
- Publication type:
- Article
Meeting the Challenges of Integrating Biosimilars in the Healthcare Treatment Paradigm.
- Published in:
- Journal of Managed Care Medicine, 2022, v. 25, n. 2, p. 22
- By:
- Publication type:
- Article
Evolving Considerations in the Treatment and Management of Metastatic Melanoma: Expert Strategies on Immune Checkpoint Inhibitors.
- Published in:
- Journal of Managed Care Medicine, 2022, v. 25, n. 2, p. 37
- By:
- Publication type:
- Article
Expanding the Role of Biosimilars: Key Advances in the Treatment Landscape.
- Published in:
- Journal of Managed Care Medicine, 2020, v. 23, n. 1, p. 54
- By:
- Publication type:
- Article
Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0132745
- By:
- Publication type:
- Article
The Role of Intralesional Therapies in Melanoma.
- Published in:
- Oncology (08909091), 2016, v. 30, n. 5, p. 436
- By:
- Publication type:
- Article
Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 12, p. 1533, doi. 10.1007/s00262-016-1910-x
- By:
- Publication type:
- Article
Immunotherapy with histamine and interleukin 2 in malignant melanoma with liver metastasis.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 9, p. 840, doi. 10.1007/s00262-004-0537-5
- By:
- Publication type:
- Article
Nivolumab and Relatlimab as Frontline Therapy in Advanced Melanoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2022, v. 20, n. 10, p. 602
- By:
- Publication type:
- Article
A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma.
- Published in:
- Cancer (0008543X), 1999, v. 85, n. 9, p. 1979, doi. 10.1002/(SICI)1097-0142(19990501)85:9<1979::AID-CNCR15>3.0.CO;2-G
- By:
- Publication type:
- Article
Continuous cyclophosphamide, doxorubicin, vincristine, and prednisolone. A new, innovative protocol for diffuse aggressive lymphomas.
- Published in:
- 1990
- By:
- Publication type:
- journal article
A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 741, doi. 10.1007/s10637-010-9562-8
- By:
- Publication type:
- Article
A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancer.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 2, p. 183, doi. 10.1007/s10637-007-9091-2
- By:
- Publication type:
- Article
Interferons in the Therapy of Solid Tumors.
- Published in:
- Oncology, 1994, v. 51, n. 2, p. 129, doi. 10.1159/000227327
- By:
- Publication type:
- Article
Management of metastatic cutaneous melanoma: updates in clinical practice.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919851663
- By:
- Publication type:
- Article
Management of metastatic cutaneous melanoma: updates in clinical practice.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919851663
- By:
- Publication type:
- Article
Safety and Efficacy of Arsenic Trioxide for Patients With Advanced Metastatic Melanoma.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 5, p. 1131, doi. 10.1002/cncr.23284
- By:
- Publication type:
- Article
Molecularly targeted therapy for melanoma.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 10, p. 2317, doi. 10.1002/cncr.22273
- By:
- Publication type:
- Article
Long‐term survivors after gamma knife radiosurgery for brain metastases.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 12, p. 2784, doi. 10.1002/cncr.21545
- By:
- Publication type:
- Article
Mature results of a phase III randomized trial of bacillus CalmetteGuerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage IIII melanoma (E1673) (The content of the study is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute.) The current study was conducted by the Eastern Cooperative Oncology Group (Robert L. Comis, M.D., Chair).)
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 8, p. 1692
- By:
- Publication type:
- Article
Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: a phase I dose-escalation study.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Temozolomide in combination with interferon α-2b in patients with metastatic melanoma.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 1, p. 121, doi. 10.1002/cncr.11041
- By:
- Publication type:
- Article
Burden of illness associated with metastatic melanoma.
- Published in:
- Cancer (0008543X), 2001, v. 91, n. 9, p. 1814, doi. 10.1002/1097-0142(20010501)91:9<1814::AID-CNCR1201>3.0.CO;2-W
- By:
- Publication type:
- Article
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st–3rd, 2022—Naples, Italy).
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04325-x
- By:
- Publication type:
- Article
Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy).
- Published in:
- 2018
- By:
- Publication type:
- research
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.
- Published in:
- 2017
- By:
- Publication type:
- historical material
The need for a network to establish and validate predictive biomarkers in cancer immunotherapy.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 1, p. 15, doi. 10.1007/s00280-023-04544-5
- By:
- Publication type:
- Article
An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 6, p. 1241, doi. 10.1007/s00280-014-2460-6
- By:
- Publication type:
- Article
Pharmacokinetics of Histamine Dihydrochloride in Healthy Volunteers and Cancer Patients: Implications for Combined Immunotherapy with Interleukin-2.
- Published in:
- Journal of Clinical Pharmacology, 2002, v. 42, n. 7, p. 774, doi. 10.1177/009127000204200708
- By:
- Publication type:
- Article
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Future perspectives in melanoma research.
- Published in:
- Journal of Translational Medicine, 2016, v. 14, p. 1, doi. 10.1186/s12967-016-1070-y
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 9, p. 370
- By:
- Publication type:
- Article
A Role for Intralesional Monotherapy in Melanoma: Debate.
- Published in:
- Personalized Medicine in Oncology, 2016, v. 5, n. 3, p. 129
- By:
- Publication type:
- Article
New Perspectives in Melanoma, Basal-Cell Carcinoma, Cutaneous T-Cell Lymphoma, and Merkel-Cell Carcinoma: Highlights from the Fourth Annual World Cutaneous Malignancies Congress.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 5, p. 252
- By:
- Publication type:
- Article
A Focus on Melanoma, Basal-Cell Carcinoma, Cutaneous T-Cell Lymphoma, Merkel-Cell Carcinoma, and Rare Cutaneous Malignancies: Highlights from the Third Annual World Cutaneous Malignancies Congress.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 2, p. 104
- By:
- Publication type:
- Article
Reflections on 2014 - Enthusiasm for 2015.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 8, p. 428
- By:
- Publication type:
- Article
The Evolution of Personalized Medicine in Oncology.
- Published in:
- Personalized Medicine in Oncology, 2014, v. 3, n. 4, p. 196
- By:
- Publication type:
- Article
Personalized Strategies for the Management of Cutaneous Malignancies: Highlights from the 2013 World Cutaneous Malignancies Congress.
- Published in:
- Personalized Medicine in Oncology, 2013, v. 2, n. 8, p. 438
- By:
- Publication type:
- Article